Stigma surrounding addiction and its treatment

Stigma surrounding addiction and its treatment operates in Dopesick as more than an attitude toward drug use: it helps determine who can speak, who is accepted as a legitimate patient, and which responses a community will support. The book follows its effects across families, treatment settings, public meetings, and institutions, showing how shame and moral judgment can obstruct care even as the epidemic becomes increasingly visible.

Shame, Disclosure, and Family Life

When reporting on heroin in the suburbs of Roanoke, Virginia, in 2012, the author found that most families were too ashamed to speak on the record. Five years later, as the book neared completion, nearly everyone agreed to be identified. That change did not mean the risks or stigma had disappeared: a few people still feared that public disclosure could threaten their jobs or safety. The contrast makes visibility itself part of the story. Families moved from concealment toward testimony, but speaking openly remained a decision with potential costs.

For Robin Roth, stigma took the form of a sense that the community marked her as a failed parent. In 2012, there were not yet Facebook groups connecting parents across the state to share rehabilitation advice, coping strategies, or practical support. Robin endured her grief in isolation and anger, much of it directed at Spencer Mumpower, whom she held responsible for the death of her only child, Scott Roth. At Spencer’s 2012 federal sentencing, she brought a framed portrait of Scott to the witness stand and addressed the consequences of his actions. The scene places private bereavement inside a criminal proceeding, while the absence of a wider parent network leaves her to carry the experience publicly and alone.

The book also shows how stigma can shape a mother’s behavior after birth. Tess Henry’s son was born healthy and showed no signs of distress. Tess was intensely protective of him, even keeping him on her own lap rather than allowing a stranger to hold him for his first photograph with Santa. A hospital neonatology nurse described such vigilance as common among mothers who had been stigmatized by friends, relatives, and hospital staff. The same nurse acknowledged that staff had previously judged these mothers harshly and misunderstood the effects of addiction. Her account marks a change in clinical understanding: condemnation gave way to recognition that supporting the mother was important to the baby’s well-being.

Treatment, Belonging, and Exclusion

Stigma also determines whether treatment is recognized as legitimate recovery. Tess Henry had attended twelve-step meetings before, but felt judged for taking buprenorphine. Some participants regarded medication-assisted treatment as incompatible with being clean or as merely replacing one opioid with another. Although Narcotics Anonymous officially accepted medication-assisted treatment, members asked to sponsor or mentor Tess declined. The gap between formal policy and individual practice left her without the peer support the meeting was meant to provide. The book presents that rejection not as an abstract disagreement over terminology but as a barrier encountered by someone trying to remain in recovery.

The divide extended beyond meetings. The book describes a sharp contrast between public-health professionals who supported medication-assisted treatment and many prosecutors and judges in Virginia drug courts who prohibited it. Drug courts could coordinate supervision and care, but restrictions on medication limited which forms of treatment participants could use. The book identifies these entrenched positions as a major obstacle to reducing overdose deaths. It also records signs of policy change: after a Kentucky appeals court required its drug courts to permit medication-assisted treatment, the Obama administration’s Office of National Drug Control Policy announced that it would withhold funding from courts that cut off access. Later federal statements and funding decisions remained contested, underscoring that wider recognition of treatment did not immediately settle the dispute.

At a service organization, Jessie Gaeta described another version of the same conflict: even groups organized around helping people could carry assumptions about who deserved support, particularly when someone did not want treatment. The account points to a practical consequence of stigma. If care is offered only to people already willing or able to enter treatment, those still ambivalent can be left outside it. The book’s discussion of low-threshold services, which did not keep patients’ names on file to build trust, offers a contrasting approach: assistance could begin with the problems people were already experiencing rather than with a demand that they first meet an institution’s expectations.

Community Silence and the Burden of Speaking

In Hidden Valley, Janine Underwood tried to make local school-board members and county officials recognize the heroin problem and support prevention work. She had chosen the school zone because she believed its affluence offered her children a safer environment, yet calls to the Hope Initiative came frequently from Hidden Valley and nearby Cave Spring. Police data showed a more severe problem in those communities than in other, less affluent parts of the county. When Janine told her family’s story at a public meeting, she received no questions or discussion. The school board declined to support the program, and the county provided its usual two thousand dollars.

That silence did not prove that the audience rejected Janine’s account, but it left her appeal without visible engagement or additional institutional support. Her experience also complicates the assumption that wealth or a carefully chosen neighborhood shields families from the crisis. The shame attached to addiction could persist in places where families had expected relative security, while public reluctance to acknowledge the problem constrained prevention efforts. In the book’s account, speaking out is necessary, but it does not guarantee that listeners will respond.

More broadly, stigma is described as a cultural barrier recurring across central Appalachia, not as a problem confined to one family or one service provider. A dispute over Narcan training for local Boy Scouts illustrates how even a measure intended to prevent death could be interpreted as encouraging drug use. The episode shows the moral suspicion that harm-reduction advocates faced: the possibility of saving someone from overdose could be recast as permission to use drugs. Against this background, community members and providers had to argue repeatedly for interventions that addressed immediate danger rather than waiting for abstinence or treatment entry.

Unequal Scrutiny and Institutional Power

The book places the moral judgment directed at people with addiction alongside the decisions and influence of pharmaceutical and regulatory institutions. The U.S. Food and Drug Administration’s 1995 review of OxyContin included information about the risks of crushing the tablets, withdrawal symptoms observed during trials, and the amount of oxycodone recoverable from a crushed pill. Yet the drug was approved, and Curtis Wright, who led the review, later worked as a consultant for Purdue Pharma. These details do not make institutional action identical to the stigma experienced by families or patients. They do, however, establish a sharp contrast between the suspicion applied to people using drugs and the authority available to organizations involved in producing, reviewing, or promoting them.

The book further describes private meetings between FDA regulators and pharmaceutical executives, held through an industry-funded nonprofit, and the development of enriched enrollment. That practice allowed drug companies to exclude study participants who did not respond well to a drug, potentially tilting studies toward approval. Separately, the American Pain Society and the American Academy of Pain Medicine advocated expanded opioid use for long-term chronic pain while receiving millions from drug manufacturers. Reporting on these relationships prompted a Senate investigation that targeted the American Pain Foundation, Purdue, and other organizations; its results remained sealed in the Senate Finance Committee’s office. The unresolved investigation stands in contrast to the visibility of families asked to explain their private suffering.

A similar disparity appears in the federal case against Purdue. Prosecutors initially considered a broader set of felony charges, while Purdue’s lawyers and allies lobbied against indicting executives on felony counts. The government’s initial proposed fine was one billion dollars; Purdue first offered ten million. In October 2006, with a plea deadline about to expire, a Justice Department official called the lead prosecutor at home at the request of a Purdue lawyer and urged more time. The prosecutor refused the pressure, and Purdue accepted the agreement that night rather than face the prospect of more serious charges or trial. These negotiations are not presented as another form of personal stigma; they show, instead, how corporate influence and institutional bargaining could shape accountability while families and people with addiction bore the more immediate burden of public blame.

Significance

Across these accounts, stigma has material consequences: it can keep families silent, isolate grieving parents, weaken access to peer support, and make lifesaving or treatment-oriented approaches politically contentious. It also changes within institutions, as shown by hospital staff reconsidering their treatment of mothers with addiction and by policy bodies beginning to challenge restrictions on medication-assisted treatment. Those changes remain incomplete. The book’s recurring contrast is between the scrutiny placed on individuals and the uneven willingness of communities and institutions to acknowledge their own role in the crisis. In that structure, stigma is not simply a prejudice surrounding addiction; it is one of the forces that shapes disclosure, care, and accountability.